据最新Ⅲ期临床数据表明 ,Adolor公司的主导产品小分子阿片受体拮抗剂alvimopan用于治疗阿片诱发的肠功能失调非常有效。以吗啡和可待因等阿片类药物治疗急慢性疼痛会引起严重便秘、腹痛和腹胀 ,过去没有有效的方法来治疗。alvimopan能显著改善此类患者的症状。alvimopan只在胃 According to the latest phase III clinical data show that Adolor’s leading product of small molecule opioid receptor antagonist alvimopan for the treatment of opioid-induced intestinal dysfunction is very effective. The treatment of acute and chronic pain with opiates, such as morphine and codeine, causes severe constipation, abdominal pain and abdominal distension. There was no effective treatment for the past. alvimopan can significantly improve the symptoms of such patients. alvimopan only on the stomach